Sherlock Biosciences Sherlock Biosciences Foundation Grants License to Rokline Health for COVID-19 CRISPR Tests Sherlock Biosciences said that under the agreement, Rokline Health will develop and manufacture high-throughput CRISPR kits in the US. Sherlock Bio Foundation Licenses CRISPR Tech to LogicInk LogicInk said it will use the CRISPR technology to develop an instrument-free diagnostic biosensor for the detection of SARS-CoV-2. Sherlock Bio Foundation Licenses CRISPR Tech to Cooper International, United PPE for COVID-19 Tests The agreements will increase access to testing in Asia through United PPE and in the Middle East through Cooper International, the foundation said. COVID-19 Pandemic Accelerated Development of CRISPR as a Diagnostic Platform in 2020 Premium The pace of development for CRISPR-based infectious disease assays increased as the pandemic progress Sherlock Biosciences Receives $5M Gates Foundation Grant for COVID-19 Self-Test The funding will help the company further develop its INSPECTR molecular diagnostic platform into a test that can be used in various settings. Dec 4, 2020 Sherlock Biosciences Licenses US Dx Rights to CRISPR-Cas12 From Tolo Biotech Nov 18, 2020 Stanford Researchers Combine CRISPR, Microfluidics, Electric Fields for SARS-CoV-2 Dx Premium Sep 21, 2020 Malaria Assays Use CRISPR for Point-of-Care Multispecies Detection Premium Sep 11, 2020 People in the News: New Appointments at CareDx, Sherlock Biosciences, DermTech, More Breaking News Roche Receives EUA for PCR-Based, Point-of-Care SARS-CoV-2 Test Decode Study Identifies Proteomic Predictors of All-Cause Mortality In Brief This Week: Natera, Bruker, Bayer, and More New Products Posted to GenomeWeb: Labcorp, Omniseq, Dovetail Genomics, DNA Script, More People in the News: New Appointments at Sema4, Strata Oncology, Bionano Genomics, More Co-Diagnostics Gets CE Mark for Saliva-Based Molecular SARS-CoV-2 Test The Scan Billions for Antivirals The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports. NFT of the Web Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports. 23andMe on the Nasdaq 23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported. Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.